Dr. Henrike Diel

Dr. Henrike Diel is currently working as a Project Manager at Oncimmune since November 2021. Prior to this, they worked as a Doktorandin at Heinrich-Heine-Universität Düsseldorf from October 2016 to April 2021. Their responsibilities included investigating the antibody response in the central nervous system (CNS), identifying antibodies produced in the CNS, cloning and expressing them in HEK293 cells, purifying the antibodies, and conducting qualitative and quantitative analysis. Dr. Henrike also determined the antigen specificity. Before that, they worked as a Werkstudentin at Richter-Helm BioLogics from January 2014 to September 2015, where they were involved in business development activities, including research and maintaining customer databases.

Dr. Henrike Diel completed their education in Biochemistry and Molecular Biology. Dr. Henrike obtained their Bachelor of Science (BS) degree from the University of Hamburg between the years 2010 and 2013. Dr. Henrike then pursued a Master of Science (MS) degree in the same field at the University of Hamburg from 2013 to 2015. Finally, they achieved their Doctorate (Dr. rer. nat.) in Biochemistry from the University of Düsseldorf from 2016 to 2021.